Floatz logo

METHADONE

Pain, Acute

Chinese University of Hong KongSmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Pain, Acute cohort.

Asset / SponsorPhaseRating
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
King Saud University
Phase 4BBB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Brian Anderson, MD
Phase 4BB
CISATRACURIUM ION
Medical University of Lublin
Phase 4BB
RAMIFENTANYL
Evangelismos Hospital
Phase 4BB
PROPOFOL
Evangelismos Hospital
Phase 4BB

View all 27 →

Same molecule, other indications

METHADONE is also rated in:

substance-related disorderDormant
BBB
Indicative ·
78 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
75 / 100
View asset →
Opiate AddictionDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →